In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. DTx deliver evidence-based therapeutic interventions to patients via software applications, and are meant to prevent, manage, or treat a broad sp … Read More »

Diabetes is an epidemic that is expected to be the seventh largest cause of death worldwide and sentencing more than 422 million people worldwide to lifelong medication. As companies across the globe continue to research new approaches to addressing both Type 1 and Type 2 di … Read More »

The achievements in the last two decades in the diagnosis, management and research on rare diseases have been unprecedented. The advancing studies of rare diseases toward genetic causes and effective therapies have been progressing rapidly. Policies and guidelines concerning … Read More »

More than 600 known neurological disorders now top the leading disease list in the developed world. With the aging of the baby-boomer population, the market for new therapies and cures has grown exponentially. Today’s CNS disease market may be on the verge of experiencing th … Read More »

Substantial progress has been made in improving women’s health in areas such as  birth control, osteoporosis, and breast cancer, yet there is still a long way to go to address other areas of disease as well as social, economic, and geographic determinants that present barrie … Read More »

The convergence of the conventional pharmaceutical industry with modern digital technologies is expected to open up a whole new set of opportunities. Digital healthcare technologies can help reduce healthcare costs and improve treatment outcomes, especially for lifestyle and … Read More »

There is no question that medicine and society benefited mightily from the Golden Age of Cardiology, from the 1970s onward, when age-adjusted death rates plummeted by as much as 70% in some western countries. Yet, cardiovascular disease remains one of the costliest disease i … Read More »

According to the World Health Organization, cancer is responsible for one in six deaths, which makes it the second-most common cause of death globally. Fortunately, we are now in an era of thriving biomedical research that has seen the field of cancer research expand into a … Read More »

A silver lining of COVID-19 has been the necessary swift exchange of information as a response to a global public health crisis. The speed and volume of the scientific knowledge are correspondingly fast and unprecedented. We are at a unique time when competition among pharma … Read More »

The simultaneous advances in biotechnology, material sciences, synthetic chemistry, and information technology are integrating to provide novel approaches to insulin-dependent diabetes that were impossible as recent as a decade ago. With more than half a billion people affec … Read More »

Despite lingering controversy, use of botanical cannabis for medicinal purposes represents the revival of a plant with historical significance reemerging in present-day healthcare.  Ultimately, as the medicinal cannabis landscape continues to evolve, practices from hospitals … Read More »

Currently, there are 5.1 million people with Alzheimer’s disease in the United States and 13 million worldwide. In 30 years, AD is expected to affect 13 million in the US, and more than 100 million worldwide. The cost of care for AD in the US is currently estimated at $267 b … Read More »

Within the mental health category, progress is being driven by FDA initiatives to encourage novel submissions, the engagement of pharmaceutical companies to assess biomarkers through development and approval, as well as the academic research conducted by the consortia of psy … Read More »

Gene therapy is based on two basic strategies: an integrating vector that is introduced into a stem cell so that the gene integrates at one or more places in the patient’s chromosomes, also known as ex vivo; and gene delivery into a nonintegrating vector to a long-lived post … Read More »